Alirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD)

Clinical trial NCT07615179 · COMPLETED

Trial details

NCT number: NCT07615179
Sponsor: Sanofi
Status: COMPLETED
Study type: OBSERVATIONAL

Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events

Start date: 2025-02-17
Primary completion: 2025-09-30
Enrollment: 4545

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.